Efficacy and safety of sofosbuvir-based therapies for treating HCV in children: observations from a real-world setting
This study confirms the excellent efficacy and good tolerability of SOF-based regimens for the treatment of hepatitis C in children aged 5 to 17 years in real-life settings, supporting the inclusion of pediatric patients in national treatment policies.
Authors
- Magdalena Marczyńska (ORCID: https://orcid.org/0000-0001-5731-6346)
- Anna Dobrzeniecka (ORCID: https://orcid.org/0000-0003-1731-2329)
- Maria Pokorska‐Śpiewak (ORCID: https://orcid.org/0000-0001-7783-6904)
- Małgorzata Aniszewska (ORCID: https://orcid.org/0000-0002-6964-0706)
- Ewa Talarek (ORCID: https://orcid.org/0000-0002-3466-0782)
Institutions
- Warsaw University of Technology (PL)
- Medical University of Warsaw (PL)
- Hospital for Tropical Diseases (VN)
Publication Details
- Journal
- European Journal of Clinical Microbiology & Infectious Diseases
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1007/s10096-025-05320-4
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00